Meric-Bernstam, F., Ford, J. M., O’Dwyer, P. J., Shapiro, G. I., McShane, L. M., Freidlin, B., … Moscow, J. A. (2023). supplementary table TS1 from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). https://doi.org/10.1158/1078-0432.22633057.v1

Meric-Bernstam, Funda, James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin, Roisin E. O’Cearbhaill, et al. “supplementary table TS1 from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH),” April 14, 2023. https://doi.org/10.1158/1078-0432.22633057.v1.

Meric-Bernstam F, Ford JM, O’Dwyer PJ, Shapiro GI, McShane LM, Freidlin B, et al. supplementary table TS1 from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). 2023.

Meric-Bernstam, Funda, et al. supplementary table TS1 from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). 14 Apr. 2023. Crossref, doi:10.1158/1078-0432.22633057.v1.

Meric-Bernstam F, Ford JM, O’Dwyer PJ, Shapiro GI, McShane LM, Freidlin B, O’Cearbhaill RE, George S, Glade-Bender J, Lyman GH, Tricoli JV, Patton D, Hamilton SR, Gray RJ, Hawkins DS, Ramineni B, Flaherty KT, Grivas P, Yap TA, Berlin J, Doroshow JH, Harris LN, Moscow JA. supplementary table TS1 from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). 2023.